Condition
Fibrosis of Liver
Total Trials
5
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Not Yet Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07359742Not ApplicableRecruiting
Assessing Signatures for Fibrosis Detection in Chronic Liver Disease: A Step Beyond Conventional Biomarkers
NCT07305324Not ApplicableNot Yet Recruiting
Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI
NCT07270822Not ApplicableNot Yet Recruiting
Screening for MASLD-related Advanced Fibrosis in Type 2 Diabetes
NCT02206841RecruitingPrimary
Establishment of NAFLD Cohort and Development of Fibrosis Markers
NCT01390194Completed
Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma
Showing all 5 trials